Lawrence Lamb, Ph.D., Incysus Therapeutics Scientific Co-Founder to Present at Allogenic Cell Therapies Summit 2019 (ACTS)
May 02, 2019 08:00 ET
|
Incysus Therapeutics, Inc.
NEW YORK, May 02, 2019 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...